Table 2.

Comparison of the Breast Cancer Screening Follow-up Rate Between the Pre-COVID Period and the COVID Period

GroupFollow-up Screening Rate,a % (95% CI)Difference, % (95% CI)
Pre-COVID PeriodbCOVID Periodc
Total78.9 (78.8 to 79.0)77.7 (77.6 to 77.8)−1.2d (−1.3 to −1.0)
Age group
40-49 years73.9 (73.7 to 74.2)74.0 (73.7 to 74.2)  0.1 (−0.3 to 0.4)
50-64 years79.7 (79.5 to 79.9)77.9 (77.6 to 78.0)−1.9d (−2.1 to −1.6)
≥65 years83.6 (83.3 to 83.8)80.3 (80.1 to 80.5)−3.2d (−3.6 to −2.9)
Race and ethnicity
Non-Hispanic White81.2 (81.0 to 81.3)80.3 (80.2 to 80.5)−0.8d (−1.0 to −0.6)
Non-Hispanic Black76.8 (76.4 to 77.1)76.3 (76.0 to 76.6)−0.4 (−0.9 to 0.0)
Non-Hispanic othere79.2 (78.3 to 80.1)74.8 (74.0 to 75.6)−4.5d (−5.7 to −3.2)
Hispanic70.8 (70.3 to 71.3)70.3 (69.8 to 70.7)−0.5 (−1.2 to 0.2)
Unknown77.4 (77.2 to 77.7)74.9 (74.7 to 75.1)−2.5d (−2.8 to −2.2)
Marital status
Married78.8 (78.5 to 79.0)76.5 (76.3 to 76.7)−2.3d (−2.6 to −2.0)
Single76.2 (75.9 to 76.5)75.1 (74.8 to 75.3)−1.1d (−1.5 to −0.7)
Unknown79.8 (79.6 to 79.9)78.8 (78.7 to 79.0)−0.9d (−1.1 to −0.7)
Regional location
Northeast80.9 (80.7 to 81.1)79.3 (79.2 to 79.5)−1.6d (−1.8 to −1.4)
South77.3 (77.0 to 77.5)76.0 (75.8 to 76.2)−1.3d (−1.6 to 1.0)
Midwest80.5 (80.3 to 80.7)80.5 (80.3 to 80.7)  0.0 (−0.3 to 0.3)
West70.6 (70.2 to 71.1)67.8 (67.4 to 68.2)−2.9d (−3.5 to −2.2)
  • a Follow-up screening rate is defined as the percentage of women who received a follow-up breast cancer screening within 24 months of their previous (index) screening.

  • b If a woman was screened during 2017, her follow-up screening was due before 2020, which was considered to be the pre-COVID period.

  • c If a woman was screened between March 1, 2019 and February 28, 2020, her follow-up screening was due between March 1, 2020 and February 28, 2022, which was considered to be the COVID period.

  • d P <.01.

  • e Asian, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander.